Month: September 2026

Cancer stayed in the headlines all through 2025, and one thread ran through nearly every story: timing. Some cancers announce themselves early. Others stay silent until the options narrow. For prostate cancer, an annual PSA test starting in midlife is what separates the two, and today's imaging has removed the old objections to getting tested. keep reading

Roughly one million prostate biopsies happen in the U.S. each year because of a high PSA result, and about 75 percent of them find no cancer at all. That is hundreds of thousands of needles for nothing. Multiparametric MRI with PI-RADS scoring, paired with PSA density, adds an accurate step in between that separates real cancer from a false alarm. keep reading